PART 7 OF 8
Recurrent Severe Hypercapnic Respiratory Failure, Near-Arrest and Hemodynamic Instability in Critical Illness
Introduction
Earlier installments of this case series described multidrug-resistant Escherichia coli urosepsis, acute kidney injury superimposed on chronic kidney disease, respiratory compromise, electrolyte abnormalities and multifactorial encephalopathy.
The subsequent clinical course was complicated by recurrent hypercapnic respiratory failure, profound acidemia, a near-arrest event and continuing ventilatory and circulatory support requirements.
This part examines the documented respiratory deterioration, the events on Hospital Day 16 (HD16), and the patient's ongoing clinical status on HD17.
Privacy Notice
Patient details have been de-identified to maintain confidentiality. Clinical information is presented solely for educational and professional discussion.
Clinical Chronology
Initial Respiratory Course
The patient initially required intermittent non-invasive ventilation (NIV), followed by a brief interval on low-flow nasal oxygen. This improvement was not sustained. Severe hypercapnic respiratory failure subsequently recurred, and continuous NIV became necessary.
An earlier blood gas showed:
pH
7.31
pCO₂
63 mmHg
The subsequent deterioration demonstrated the severity and fluctuating nature of the patient's respiratory course.
Hospital Day 16 (HD16): Profound Hypercapnic Acidemia and Near-Arrest
On HD16, blood gas findings included:
HD16 | DOCUMENTED BLOOD GAS FINDINGS
pH: 6.84
pCO₂: >150 mmHg
These findings documented extreme hypercapnic acidemia.
A near-arrest event was recorded. Adrenaline was administered, after which an organised rhythm was documented.
The available clinical narrative does not specify whether pulselessness occurred, whether chest compressions were performed, or the mechanism responsible for the respiratory collapse. Therefore, this event is described as a near-arrest episode rather than a confirmed cardiac arrest or documented return of spontaneous circulation.
Hospital Day 17 (HD17): Subsequent Blood Gas Findings
The documented blood gas on HD17 showed:
| Parameter | Recorded Value |
|---|---|
| pH | 7.33 |
| pCO₂ | 49 mmHg |
| pO₂ | 50 mmHg |
| HCO₃ | 24.1 mmol/L |
| Lactate | 1.8 mmol/L |
The sample type, inspired oxygen concentration and contemporaneous oxygen saturation are unavailable in the case narrative. Accordingly, the pO₂ value should not be interpreted as confirmed arterial hypoxemia.
Although pH and pCO₂ improved substantially compared with HD16, NIV dependence and depressed sensorium persisted.
Clinical Perspective
Improvement in selected blood gas parameters did not establish complete respiratory stabilisation or recovery.
Concurrent Organ Support
Noradrenaline was required in the setting of septic shock.
A fifth haemodialysis session was documented at approximately 06:00 on HD17. However, no causal relationship between dialysis and the improvement in blood gas values can be established from the available information.
The continued requirement for respiratory and circulatory support indicated persistent critical illness despite improvement in selected laboratory parameters.
Clinical Interpretation
This episode demonstrates why a corrected blood gas cannot be used as a surrogate for clinical recovery.
Sustained improvement requires concordant clinical findings, including:
Persistent altered sensorium and vasopressor dependence are particularly important when assessing whether NIV remains safe and effective.
The profound acidemia and extreme hypercapnia documented on HD16 required immediate senior-level reassessment of ventilation and airway safety.
Clinical guidelines support NIV in selected patients with acute hypercapnic respiratory failure. However, they caution against delaying invasive ventilation when deterioration or peri-arrest physiology is present. The appropriate airway and ventilation decision in this individual episode cannot be retrospectively determined without additional bedside documentation.
Bedside Framework: What Carries the Greatest Weight?
When assessing respiratory stabilisation in a critically ill patient, several domains need to be considered together.
1. Airway and Neurological Status
Assess the patient's ability to protect the airway, manage secretions and maintain an adequate level of consciousness.
2. Clinical Respiratory Trajectory
Evaluate respiratory rate, work of breathing, respiratory effort, fatigue, synchrony and the continuing need for uninterrupted NIV.
3. Gas Exchange
Interpret serial pH and pCO₂ values alongside SpO₂, oxygen delivery and confirmed blood gas sample type.
4. Circulation
Review perfusion, blood pressure trends and the trajectory of vasopressor requirements.
5. Escalation Readiness
A predefined plan is essential if NIV fails. Decisions about escalation must remain aligned with the patient's documented goals of care.
Important Clinical Learning Points
Key Takeaway
In multisystem critical illness, a favourable laboratory trend may coexist with ongoing organ-support dependence.
Respiratory stabilisation is a clinical judgement based on the patient's trajectory, airway safety, ventilation, oxygenation and perfusion—not on a single blood gas result.
Clinical Discussion
When pH and pCO₂ improve but NIV dependence, depressed consciousness and circulatory instability persist, which bedside findings should determine whether the patient has genuinely stabilised?
Looking Ahead: Part 8
The concluding installment will examine the subsequent documented clinical course, terminal event and overall outcome, without retrospectively assigning unsupported mechanisms.